Abstract

Summary

This paper discusses the results of a clinical trial testing the efficacy and safety of tasimelteon in treating Jet Lag Disorder in healthy participants.
Categories

Categories

Jet lag: The paper discusses a clinical trial testing the efficacy and safety of tasimelteon in treating Jet Lag Disorder in healthy participants.
Sleep and insomnia: The paper discusses how tasimelteon can help improve sleep time and reduce next-day sleepiness in participants experiencing Jet Lag Disorder.
Alertness and performance: The paper discusses how tasimelteon can help increase next-day alertness in participants experiencing Jet Lag Disorder.
Hormone regulation: The paper discusses how tasimelteon, a Dual Melatonin Receptor Agonist, can regulate the timing of melatonin secretion and help entrain the circadian clock of individuals.
Authors

Author(s)

CM Polymeropoulos, MA Mohrman, MS Keefe
Publication Date

Publication Year

2020
Related

Related Publications

View more publications